Regeneron works on UK, South African Covid-19 variants: company

  • 📰 theSundaily
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

WASHINGTON, Jan 28: Regeneron’s synthetic antibody treatment remains effective against the British and South African variants of the novel coronavirus...

Stewards wait to receive members of the public arriving to receive a dose of a Covid-19 vaccine at a vaccination centre set up at Lords Cricket Ground in London on January 27, 2021. Over 30 new coronavirus vaccination centres were set to open around England this week as Britain’s largest ever innoculation programme continued to gain pace.

Scientists from New York’s Columbia University arrived at the same conclusion, and their study has been submitted for peer review. Bamlanivimab will likely also be ineffective against the new Brazilian variant, since it presents mutations similar to the South African variant, scientists said. “With two complementary antibodies in one therapeutic, even if one has reduced potency, the risk of the cocktail losing efficacy is significantly diminished.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

 /  🏆 25. in İD
 

Terima kasih atas komentar Anda. Komentar Anda akan dipublikasikan setelah ditinjau.

Indonesia Berita Terbaru, Indonesia Berita utama